Intrauterine Balloon Tamponade May Cut Invasive Procedures

Share this content:
Intrauterine Balloon Tamponade May Cut Invasive Procedures
Intrauterine Balloon Tamponade May Cut Invasive Procedures

WEDNESDAY, Dec. 27, 2017 (HealthDay News) -- For women undergoing vaginal delivery, the use of intrauterine balloon tamponade is associated with a significantly lower use of invasive procedures for hemorrhage control, according to a study published online Dec. 4 in Obstetrics & Gynecology.

Mathilde Revert, from Versailles Saint Quentin University in France, and colleagues assessed rates of invasive procedures for hemorrhage control among 72,529 women delivering between 2011 and 2012 in two French perinatal networks: a pilot in which balloon tamponade was used and a control network.

The researchers found that invasive procedures were used in 298 women, representing 4.1 per 1,000 deliveries. The pilot network had a significantly lower proportion of women with at least one invasive procedure (3 versus 5.1/1,000). The pilot network also had significantly lower use of arterial embolization for those who delivered vaginally and by cesarean. The risk of an invasive procedure remained significantly lower in the pilot network for women who delivered vaginally (adjusted odds ratio, 0.14; 95 percent confidence interval, 0.08 to 0.27), but not for women who delivered by cesarean section (adjusted odds ratio, 1.19; 95 percent confidence interval, 0.87 to 1.61), after the researchers controlled for potential confounding variables.

"Our results seem to confirm the association between intrauterine balloon tamponade and a significantly lower rate of invasive procedures among women undergoing vaginal delivery," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »